Saiboku-to

Drug Profile

Saiboku-to

Alternative Names: TJ 96

Latest Information Update: 13 Aug 2002

Price : $50

At a glance

  • Originator Tsumura
  • Class Antiallergics; Antiasthmatics; Phytotherapies
  • Mechanism of Action Beta-adrenergic receptor agonists; Histamine release inhibitors; Platelet activating factor inhibitors; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Asthma; Respiratory tract disorders

Most Recent Events

  • 13 Aug 2002 A study has been added to the adverse events and Obstructive Airways Disease therapeutic trials sections
  • 12 Jul 1999 An in vitro study has been added to the pharmacodynamics section
  • 24 Nov 1998 Profile reviewed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top